Prof Jacintha O'Sullivan on Esophageal Cancer
Updated: Apr 25, 2021
Professor Jacintha O'Sullivan explains her research ('Gold-drug: Targeting a novel dual inhibitor drug with gold nanoparticles for improving radiation response in oesophageal cancer) and the discovery of a novel drug which makes the tumour responsive to medication and will provide a more targeted treatment. Professor O'Sullivan also explains the impact that this research will have on those patients living with cancer.
Find out more about Prof O'Sullivan research here.